A Protocol for Simple, Rapid, and Direct Detection of SARS-CoV-2 from clinical samples, using Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP).

Colorimetric Covid-19 Isothermal Pandemic RT-LAMP Rapid molecular Detection SARS-CoV-2 Saliva.

Journal

Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102

Informations de publication

Date de publication:
20 Oct 2020
Historique:
received: 14 06 2020
revised: 18 08 2020
accepted: 20 08 2020
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 5 3 2021
Statut: epublish

Résumé

SARS-CoV-2 has quickly spread all around the globe causing illness and wide damages. Most countries were unprepared for such a rapid spread and crisis. This led to various strategies for effective control of the new pandemic. A key aspect in all countries was to effectively test the population for the virus. Most countries chose a lockdown strategy in which many workplaces and activities are completely closed, leading to substantial economy costs. Here, we present a protocol we recently developed that allows rapid and simple detection of SARS-CoV-2 for the large population, eliminating costs and involvement of professional teams and laboratories. This protocol is based on Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP). We tested this protocol directly on patient samples, both nasal and throat clinical swabs as well as saliva. Notably, this protocol is simple, cheap and can be easily applied to other pathogens as well.

Identifiants

pubmed: 33659444
doi: 10.21769/BioProtoc.3789
pii: e3789
pmc: PMC7842347
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e3789

Informations de copyright

Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Déclaration de conflit d'intérêts

Competing interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. While performing this research, no company had invested in the research, and no commercialization was intended.

Références

Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Exp Biol Med (Maywood). 2020 Aug;245(14):1187-1193
pubmed: 32668983
J Virol Methods. 2016 Dec;238:86-93
pubmed: 27793644
PLoS Biol. 2020 Oct 2;18(10):e3000896
pubmed: 33006983
Clin Chem. 2020 Jul 1;66(7):975-977
pubmed: 32315390
J Virol Methods. 2018 May;255:91-97
pubmed: 29474813

Auteurs

Rawi Naddaf (R)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.

Nadav Ben-Assa (N)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.

Tal Gefen (T)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.

Tal Capucha (T)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.
Oral and Maxillofacial Surgery Department, Rambam Medical Care Center, Haifa, 3525433, Israel.

Haitham Hajjo (H)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.
Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Neuroscience, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Noa Mandelbaum (N)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.

Lilach Elbaum (L)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.

Shai Kaplan (S)

Robiotec ltd 9 Aharonwitz st. Rehovot, 7634709, Israel.

Assaf Rotem (A)

47 Bow Rd, Newton MA 02459, USA.

Michal Chowers (M)

Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Moran Szwarcwort-Cohen (M)

Virology Laboratory, Rambam Health Care Campus, Haifa, Israel.

Mical Paul (M)

Division of Infectious Diseases, Rambam Health Care Center and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Naama Geva-Zatorsky (N)

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa, 3525433, Israel.
Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholar, MaRS Centre, West Tower 661 University Ave., Suite 505 Toronto, ON M5G 1M1, Canada.

Classifications MeSH